Skip links

EULAR 2024, June 12-15, 2024, Vienna, AT

SavetheDate: OncoOne’s Vice President of Preclinical and Translational R&D Christine Landlinger-Schubert, and Senior Scientist Maroua FERHAT will be attending EULAR2024 in Vienna. They will present a poster on our lead asset, ON104. This is a great opportunity to learn about the potential of our novel bioengineered monoclonal antibody targeting oxMIF as a new treatment for rheumatoid arthritis.

Download the poster here.

Home